Hood River Capital Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Hood River Capital Management’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-615,905	Closed	-$15.7M	–	117
2018 Q2	$15.7M	Buy	615,905 +26,508	+4%	+$618K	0.81%	60
2018 Q1	$11.9M	Buy	+589,397	New	+$13.8M	0.67%	66
2016 Q4	–	Sell	-15,504	Closed	-$434K	–	107
2016 Q3	$434K	Sell	15,504 -249,884	-94%	-$8.39M	0.04%	85
2016 Q2	$9.29M	Sell	265,388 -150,596	-36%	-$4.73M	1.24%	34
2016 Q1	$11.4M	Sell	415,984 -490,725	-54%	-$14.5M	1.52%	23
2015 Q4	$31M	Buy	+906,709	New	+$28.3M	3.97%	1

Other funds holding DPLO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Hood River Capital Management's DPLO Position: Q3 2018 in Review

Hood River Capital Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q3 2018, closing a stake of 615,905 shares — an estimated $15.7M sold.

Hood River Capital Management first reported a position in DPLO in Q4 2015 and held it in 6 quarters. The position peaked at $31M in Q4 2015. 178 funds tracked by Wall St. Rank hold DPLO as of Q3 2018.

Hood River Capital Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q3 2018 after selling out during the quarter.
Hood River Capital Management sold 615,905 DIPLOMAT PHARMACY, INC. shares in Q3 2018, an estimated $15.7M.
Hood River Capital Management first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2015 and held it in 6 quarters.
Hood River Capital Management's DIPLOMAT PHARMACY, INC. position peaked at $31M in Q4 2015.
178 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q3 2018.

Based on Hood River Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.